Casago completes acquisition of Vacasa in $130 million deal

PHOENIX, AZ and PORTLAND, OR, May 1, 2025 – Casago, a premier vacation rental property management company, today announced the completion of its acquisition of Vacasa, Inc. (“Vacasa” or the “Company”), a leading vacation rental management platform in North America. The transaction, a watershed moment for the U.S. vacation rental industry, combines…Read More

Read More
Virtana Acquires Zenoss to Deliver the Industry’s Deepest and Broadest Observability Platform

PALO ALTO, CA May 14 2025 – Virtana, the leader in deep hybrid-infrastructure observability, today announced it has acquired Zenoss, a pioneer in real-time IT service monitoring and a leader in AI-powered event intelligence. This strategic acquisition aims to bridge the gap between service visibility and infrastructure control in hybrid…Read More

Read More
LogicMark, Inc. Announces Closing of $14.4 Million Public Offering

LOUISVILLE, KY, February 18, 2025 (Globe Newswire) LogicMark, Inc. (NASDAQ: LGMK) (the “Company”), a provider of personal emergency response systems, health communications devices, and technology for the growing care economy, today announced the closing of its public offering. The public offering consisted of 2,260,000 units and 22,146,750 pre-funded units, with…Read More

Read More
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine

SEATTLE, WA – March 17, 2025 Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improved tolerability, today announces the closing of a $110 million Series B round to advance development of amezosvatein, its vaccine for shingles. FLG Leading the round is…Read More

Read More
Saluda Medical Announces Closing of $100 Million Financing

MINNEAPOLIS, MN — January 10, 2025 (PR Newswire) Saluda Medical, Inc., a commercial-stage medical device company focused on development treatments for chronic neurological conditions using a novel closed-loop, dose-control neuromodulation platform, today announced the closing of a $100 million financing. FLG Managing Partner Laureen DeBuono assisted as Board of Directors…Read More

Read More